Thus, the functions of TNFR2+MSCs go beyond their direct immunosuppressive activity in the TME to indirectly trigger and activate numerous immunosuppressive cells, enabling BC cell immune escape, proliferation, progression, and treatment resistance. Here, TNFRSF1B is linked to breast cancer.